562 related articles for article (PubMed ID: 198601)
21. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
Vessby B; Carlson LA
Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
[TBL] [Abstract][Full Text] [Related]
22. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
Weisweiler P; Schwandt P
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
[No Abstract] [Full Text] [Related]
23. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
24. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
Miettinen TA; Penttilä IM; Lampainen E
Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
[No Abstract] [Full Text] [Related]
25. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
Vessby B; Hedstrand H; Olsson U
Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
[TBL] [Abstract][Full Text] [Related]
27. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
28. Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia.
Weisweiler P; Schwandt P
Atherosclerosis; 1978 Sep; 31(1):53-8. PubMed ID: 213086
[TBL] [Abstract][Full Text] [Related]
29. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
30. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
31. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
Hazzard ER; Bierman EL
J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
[TBL] [Abstract][Full Text] [Related]
32. Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
Gavish D; Oschry Y; Fainaru M; Eisenberg S
Eur J Clin Invest; 1986 Feb; 16(1):61-8. PubMed ID: 3084275
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of hyperlipoproteinemia type IIa with a "prudent" diet and clofibrate (author's transl)].
Mertz DP; Suermann J
Med Klin; 1978 Jun; 73(23):867-73. PubMed ID: 207959
[TBL] [Abstract][Full Text] [Related]
34. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
Haacke H; Parwaresch MR; Mäder C
Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036
[TBL] [Abstract][Full Text] [Related]
35. Influence of clofibrate on blood viscosity in primary hyperlipoproteinemia.
Arntz HR; Leonhardt H; Dreykluft HR
Klin Wochenschr; 1979 Jan; 57(1):43-7. PubMed ID: 215822
[TBL] [Abstract][Full Text] [Related]
36. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
37. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
Bagnall TF; Lloyrd JK
Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
[TBL] [Abstract][Full Text] [Related]
38. Hypolipidaemic agents: What are they good for?
Manninen V; Mälkönen M; Tuomilehto J
Lancet; 1977 Dec; 2(8051):1281-2. PubMed ID: 73969
[No Abstract] [Full Text] [Related]
39. One-year trials with halofenate, clofibrate, and placebo.
Dujovne CA; Azarnoff DL; Huffman DH; Pentikäinen P; Hurwitz A; Shoeman DW
Clin Pharmacol Ther; 1976 Mar; 19(3):352-9. PubMed ID: 177242
[TBL] [Abstract][Full Text] [Related]
40. Bile acid metabolism in hyperlipoproteinaemia.
Hellström K; Einarsson K
Clin Gastroenterol; 1977 Jan; 6(1):103-28. PubMed ID: 196796
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]